Virological and Clinical Anti-HBV Efficacy of Tenofovir in Antiretroviral naïve Patients With HIV/HBV Co-infection

Trial Profile

Virological and Clinical Anti-HBV Efficacy of Tenofovir in Antiretroviral naïve Patients With HIV/HBV Co-infection

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2015

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary) ; Efavirenz; Lamivudine; Lamivudine/zidovudine; Zidovudine
  • Indications Hepatitis B; HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms TICO
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Apr 2009 Results published in Hepatology.
    • 10 Apr 2008 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top